Thyroid cancer (TC) remains the most common endocrine malignancy worldwide and its incidence and mortality have increased steadily over the last four decades. Thyroid cancer is commonly diagnosed at a younger age than most other adult cancers. Therefore, in order to improve the benefit of screening and the survival rate of patients, it is very important to establish a system of early diagnosis and targeted therapy for thyroid cancer. In the episode, we will give you a comprehensive introduction to thyroid cancer and its signaling pathways, diagnostic markers, and targeted therapies, as well as Creative Biolabs' antibody-related products and services.
